What Hugel, Inc.'s (KOSDAQ:145020) P/E Is Not Telling You
Jan 28
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthcare Sector Analysis
UpdatedFeb 01, 2025
DataAggregated Company Financials
Companies362
- 7D0.2%
- 3M2.6%
- 1Y18.8%
- YTD6.8%
The Healthcare industry has stayed flat over the last week. The past year has been better, since the industry has gained 19% in that time. Looking forward, earnings are forecast to grow by 48% annually.
Sector Valuation and Performance
Has the South Korean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Feb 2025 | ₩272.1t | ₩54.6t | ₩831.2b | 14.7x | 327.4x | 5x |
| Mon, 30 Dec 2024 | ₩250.0t | ₩54.4t | ₩803.1b | 13.6x | 311.3x | 4.6x |
| Wed, 27 Nov 2024 | ₩245.3t | ₩54.2t | ₩805.0b | 13x | 304.7x | 4.5x |
| Fri, 25 Oct 2024 | ₩275.6t | ₩53.3t | ₩854.8b | 16x | 322.4x | 5.2x |
| Sun, 22 Sep 2024 | ₩279.8t | ₩53.4t | ₩856.4b | 17.2x | 326.7x | 5.2x |
| Tue, 20 Aug 2024 | ₩264.2t | ₩52.3t | ₩767.6b | 16.1x | 344.2x | 5.1x |
| Thu, 18 Jul 2024 | ₩250.2t | ₩52.3t | ₩750.8b | 16.8x | 333.2x | 4.8x |
| Sat, 15 Jun 2024 | ₩226.8t | ₩53.0t | ₩740.9b | 16.6x | 306.1x | 4.3x |
| Mon, 13 May 2024 | ₩236.3t | ₩52.3t | ₩544.9b | 18.4x | 433.6x | 4.5x |
| Wed, 10 Apr 2024 | ₩231.4t | ₩52.3t | ₩463.2b | 17.3x | 499.6x | 4.4x |
| Fri, 08 Mar 2024 | ₩228.6t | ₩52.1t | -₩122,882,827,436.00 | 21.2x | -1860.1x | 4.4x |
| Sun, 04 Feb 2024 | ₩241.5t | ₩55.7t | ₩32.1b | 22.6x | 7529.7x | 4.3x |
| Tue, 02 Jan 2024 | ₩232.1t | ₩56.1t | ₩268.1b | 22.9x | 865.6x | 4.1x |
| Thu, 30 Nov 2023 | ₩209.0t | ₩56.1t | ₩352.7b | 20.1x | 592.7x | 3.7x |
| Sat, 28 Oct 2023 | ₩195.5t | ₩56.0t | ₩1.0t | 18.2x | 191.1x | 3.5x |
| Mon, 25 Sep 2023 | ₩206.5t | ₩56.0t | ₩1.0t | 18.8x | 201.7x | 3.7x |
| Wed, 23 Aug 2023 | ₩213.7t | ₩55.6t | ₩1.4t | 23x | 150x | 3.8x |
| Fri, 21 Jul 2023 | ₩207.4t | ₩56.1t | ₩2.1t | 21x | 98.5x | 3.7x |
| Sun, 18 Jun 2023 | ₩213.9t | ₩56.3t | ₩2.1t | 21.4x | 101.4x | 3.8x |
| Tue, 16 May 2023 | ₩213.0t | ₩58.4t | ₩3.3t | 20.6x | 64.8x | 3.6x |
| Thu, 13 Apr 2023 | ₩221.6t | ₩58.4t | ₩3.3t | 20.1x | 68.2x | 3.8x |
| Sat, 11 Mar 2023 | ₩202.4t | ₩58.1t | ₩4.5t | 18.7x | 45x | 3.5x |
| Mon, 06 Feb 2023 | ₩211.1t | ₩57.8t | ₩4.6t | 19.6x | 45.8x | 3.7x |
| Wed, 04 Jan 2023 | ₩202.5t | ₩58.0t | ₩4.4t | 16.3x | 46.3x | 3.5x |
| Fri, 02 Dec 2022 | ₩212.0t | ₩57.4t | ₩4.1t | 16.8x | 51.7x | 3.7x |
| Sun, 30 Oct 2022 | ₩201.8t | ₩55.7t | ₩4.1t | 15.2x | 49.5x | 3.6x |
| Tue, 27 Sep 2022 | ₩186.6t | ₩56.0t | ₩4.1t | 15.9x | 45.2x | 3.3x |
| Thu, 25 Aug 2022 | ₩218.5t | ₩55.0t | ₩4.1t | 18.9x | 53.8x | 4x |
| Sat, 23 Jul 2022 | ₩223.6t | ₩54.2t | ₩3.9t | 20.2x | 57.5x | 4.1x |
| Mon, 20 Jun 2022 | ₩208.1t | ₩54.2t | ₩3.9t | 19.3x | 53.3x | 3.8x |
| Wed, 18 May 2022 | ₩213.9t | ₩51.1t | ₩3.9t | 20.8x | 55.1x | 4.2x |
| Fri, 15 Apr 2022 | ₩228.7t | ₩51.0t | ₩4.0t | 23.2x | 57.1x | 4.5x |
| Sun, 13 Mar 2022 | ₩228.6t | ₩49.2t | ₩4.3t | 22.3x | 53.1x | 4.6x |
| Tue, 08 Feb 2022 | ₩224.9t | ₩49.0t | ₩4.3t | 21.1x | 52x | 4.6x |
Price to Earnings Ratio
52x
Current Industry PE
- Investors are optimistic on the South Korean Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 327x which is higher than its 3-year average PE of 232x.
- The 3-year average PS ratio of 4.1x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 42% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare sector?
| KR Market | -0.70% | |
| Healthcare | 0.16% | |
| Medical Equipment | 0.69% | |
| Pharma | 0.42% | |
| Biotech | 0.40% | |
| Healthcare Services | -0.25% | |
| Life Sciences | -0.31% | |
| Healthtech | -2.60% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 111x.
- Analysts are expecting annual earnings growth of 21.0%, which is lower than the prior year's growth of 39.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 85% over the next 5 years.
- This is better than its past earnings growth rate of 7.9% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 21% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A196170 ALTEOGEN | ₩371.50k | 2.6% +₩506.3b | 386.3% | PS266.2x | |
| A000250 Sam Chun Dang Pharm | ₩184.00k | 7.0% +₩279.1b | 180.9% | PE837.4x | |
| A028300 HLB | ₩80.40k | 1.6% +₩170.5b | 14.5% | PS203.1x | |
| A141080 LigaChem Biosciences | ₩126.50k | 3.3% +₩145.9b | 160.0% | PS45.5x | |
| A310210 Voronoi | ₩86.10k | 7.2% +₩104.1b | 155.5% | PB20.7x |
